-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
LakeShore Biopharma Co., Ltd. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q1 2023 to Q1 2024.
- LakeShore Biopharma Co., Ltd. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending March 31, 2024 was $62.6M, a 7.1% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)